[
    {
        "other_ids": [],
        "amendment_date": "2020-03-03",
        "keywords": null,
        "dcp_id": null,
        "interventional_model": "Single Group",
        "lead_org": "Icahn School of Medicine at Mount Sinai",
        "eligibility": {
            "unstructured": [
                {
                    "inclusion_indicator": true,
                    "display_order": 1,
                    "description": "Women with histologically confirmed estrogen receptor (ER) =< 10% and or PR =< 10% TNBC on the pre-trial metastatic biopsy"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 2,
                    "description": "=< 3 prior chemotherapies for metastatic disease"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 3,
                    "description": "Prior immunotherapy is permitted and does not count as chemotherapy"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 4,
                    "description": "The use denosumab or zoledronic is permitted"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 5,
                    "description": "History of previously treated brain metastases with >= 4 weeks after definitive surgery and gamma knife/whole brain radiation and not taking steroids"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 6,
                    "description": ">= 2 weeks from last oral or IV chemotherapy, small molecule inhibitor, or biologic agent, >= 4 weeks from last surgery or radiation"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 7,
                    "description": "Performance status 0-2"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 8,
                    "description": "Leukocytes >= 3,000/mcL"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 9,
                    "description": "Absolute neutrophil count >= 1,000/mcL"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 10,
                    "description": "Platelets >= 100,000/mcl"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 11,
                    "description": "Total bilirubin within institutional upper limit of normal. (=< ULN)"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 12,
                    "description": "Aspartate aminotransferases (AST)(serum glutamic-oxaloacetic transaminase [SGOT])/alanine aminotransferase (ALT)(serum glutamate pyruvate transaminase [SGPT]) =< 2 x ULN"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 13,
                    "description": "Creatinine =< ULN"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 14,
                    "description": "A negative serum or urine pregnancy test within 3 days of receiving day 1 cycle 1 of leflunomide"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 15,
                    "description": "Women of child-bearing potential and men must agree to use adequate contraception before study entry, for the duration of study participation, and for 90 days following completion of therapy. Should a woman become pregnant or suspect she is pregnant while participating in this study, she should inform her treating physician immediately"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 16,
                    "description": "Recommended methods of birth control are: The consistent use of an approved hormonal contraception such as an intrauterine device (IUD), double barrier methods (diaphragm with spermicidal gel or condoms with contraceptive foam), sexual abstinence (no sexual intercourse) or sterilization. The use of hormonal forms of birth control is controversial in TNBC and as such women enrolled in the trial are permitted to use birth control pills or depot Provera, only after a documented discussion by the treating physician as too the uncertain risks of hormonal birth control methods in the TNBC population. A female of child-bearing potential is any woman (regardless of sexual orientation, having undergone a tubal ligation, or remaining celibate by choice) who meets the following criteria: \r\n* Has not undergone a hysterectomy or bilateral oophorectomy; or \r\n* Has not been naturally postmenopausal for at least 12 consecutive months (i.e., has had menses at any time in the preceding 12 months)"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 17,
                    "description": "Ability to understand and the willingness to sign a written informed consent"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 18,
                    "description": "Patients who have had chemotherapy or radiotherapy within 4 weeks before entering the study or those who have not recovered from adverse events due to agents administered more than 4 weeks earlier"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 19,
                    "description": "Patients may not be receiving any other investigational agents"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 20,
                    "description": "The known history human immunodeficiency virus, acute and chronic hepatitis B or C, or acute or previously treated tuberculosis"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 21,
                    "description": "Patients with untreated brain metastases should be excluded from this clinical trial because of their poor prognosis and because they often develop progressive neurologic dysfunction that would confound the evaluation of neurologic and other adverse events"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 22,
                    "description": "History of allergic reactions attributed to compounds of similar chemical or biologic composition to leflunomide or teriflunomide"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 23,
                    "description": "Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 24,
                    "description": "Patients must not be pregnant or nursing due to the potential for congenital abnormalities and the potential of this regimen to harm nursing infants"
                }
            ],
            "structured": {
                "max_age": "999 Years",
                "max_age_number": 999.0,
                "min_age_unit": "Years",
                "max_age_unit": "Years",
                "max_age_in_years": 999.0,
                "gender": "FEMALE",
                "accepts_healthy_volunteers": false,
                "min_age": "18 Years",
                "min_age_number": 18.0,
                "min_age_in_years": 18.0
            }
        },
        "completion_date_type_code": "ANTICIPATED",
        "detail_description": "PRIMARY OBJECTIVES:\r\nI. To determine the safety and tolerability and the maximum tolerated dose (MTD) of leflunomide in women with previously treated metastatic triple negative breast cancer. (Phase I)\r\nII. To determine the efficacy of leflunomide in patients with metastatic triple negative breast cancer (TNBC) PTEN null (30-50% of TNBC) and patients with PTEN wild type. (Phase II)\r\nIII. To evaluate the clinical benefit rate (CBR) (complete response [CR]+partial response [PR]+stable disease [SD]) in women with metastatic TNBC, in two cohorts, one PTEN null, and the other PTEN wild type. (Phase II)\r\n\r\nSECONDARY OBJECTIVES:\r\nI. To describe the adverse events associated with oral leflunomide. (Phase I)\r\nII. To describe the adverse events associated with oral leflunomide. (Phase II)\r\nIII. To measure the objective response rate in those with measurable disease. (Phase II)\r\nIV. To measure the progression free survival (PFS) in the two cohorts of PTEN wild and null TNBC. (Phase II)\r\n\r\nEXPLORATORY OBJECTIVES:\r\nI. To determine PTEN protein expression.\r\nII. To measure expression of gamma-H2X in circulating tumor cells (CTCs) (express increased in PTEN null tumors relative to PTEN wild-type after treatment with leflunomide.\r\n\r\nOUTLINE: This is a phase I dose-escalation study followed by a phase II study.\r\n\r\nPatients receive leflunomide orally (PO) once daily (QD) in the absence of disease progression or unacceptable toxicity.\r\n\r\nAfter completion of study treatment, patients are followed up every 3 months for 1 year.",
        "official_title": "A Phase I/II Trial of Leflunomide in Women with Previously Treated Metastatic Triple Negative Cancers",
        "_phase_sort_order": 3,
        "collaborators": [
            {
                "name": "National Cancer Institute",
                "functional_role": "FUNDING_SOURCE"
            }
        ],
        "associated_studies": [],
        "outcome_measures": [
            {
                "timeframe": "6 months up to 1 year post treatment",
                "name": "Clinical Benefit Rate (CBR) (Phase II)",
                "description": "CBR is defined as the proportion of patients having a complete response (CR), or a partial response (PR), or stable disease (SD) of at least 6 months duration, according to Response Evaluation Criteria in Solid (RECIST) version 1.1 criteria. The CBR will be estimated separately for patients with phosphatase and tensin homolog (PTEN) null tumors and PTEN wild-type tumors with a two-sided 95% confidence interval by the Clopper Pearson method.",
                "type_code": "PRIMARY"
            },
            {
                "timeframe": "Baseline up to 1 year post treatment",
                "name": "Gamma-H2X expression levels",
                "description": "Circulating tumor cells (CTC) will be collected at baseline, after one treatment cycle of leflunomide, after three treatment cycles, and at the time of progression, and measured for expression levels of gamma-H2X. Levels of gamma-H2X in CTC of patients having PTEN null tumors will be compared over time with patients having PTEN wild-type tumors by a repeated measures mixed model analysis.",
                "type_code": "OTHER_PRE_SPECIFIED"
            },
            {
                "timeframe": "Up to 1 year post treatment",
                "name": "Incidence of adverse events (AEs)",
                "description": "AEs will be reported according to the National Cancer Institute Common Terminology Criteria for Adverse Events version 4.03 criteria by organ system grouping and severity.",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Up to 3 months",
                "name": "Maximum tolerated dose (MTD) (Phase I)",
                "description": "Dose-limiting toxicity (DLT) is defined as any grade 3 or higher toxicity seen during the first 3-week cycle. Will be graded by National Cancer Institute Common Terminology Criteria for Adverse Events version 4.03.",
                "type_code": "PRIMARY"
            },
            {
                "timeframe": "Up to 1 year post treatment",
                "name": "Objective response rate (ORR)(proportion of patients with CR or PR)",
                "description": "Will be estimated with a two-sided 95% confidence interval by the Clopper\r\nPearson method separately for the two PTEN tumor types.",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Time from the start of treatment to the first occurrence of disease progression or death from any cause, assessed up to 1 year post treatment",
                "name": "Progression-free survival (PFS)",
                "description": "PFS will be estimated by PTEN positivity group by the Kaplan-Meier method. PFS will also be compared between patients with PTEN wild-type and PTEN null pre-trial metastatic biopsies by the log-rank test.",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "At baseline",
                "name": "PTEN protein expression",
                "description": "PTEN protein expression will be measured in tumors at the metastatic site of patients at baseline by immunohistochemistry (IHC). A measure of the percentage of PTEN positive cells will be obtained for each patient.",
                "type_code": "OTHER_PRE_SPECIFIED"
            }
        ],
        "phase": "I_II",
        "central_contact": {
            "phone": null,
            "name": null,
            "type": null,
            "email": null
        },
        "primary_purpose": "TREATMENT",
        "number_of_arms": 1,
        "_study_protocol_type_sort_order": 0,
        "nct_id": "NCT03709446",
        "biomarkers": [
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Absent",
                    "LOST",
                    "Loss of Expression",
                    "Negative",
                    "Not Expressed"
                ],
                "nci_thesaurus_concept_id": "C165233",
                "name": "Expression Negative",
                "semantic_types": [
                    "Cell or Molecular Dysfunction"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C35681",
                    "C3367",
                    "C77140"
                ],
                "parents": [
                    "C35681"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Diagnostic Test Result",
                    "Test Result"
                ],
                "nci_thesaurus_concept_id": "C77140",
                "name": "Clinical Test Result",
                "semantic_types": [
                    "Finding"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C3367"
                ],
                "parents": [
                    "C3367"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C25872",
                "name": "Kinase Family Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C25870",
                    "C16612",
                    "C21281",
                    "C25871"
                ],
                "parents": [
                    "C25871"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C21295",
                "name": "Ligand Binding Protein Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C16612"
                ],
                "parents": [
                    "C16612"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TRIAL",
                "synonyms": [
                    "ERBB2 Negative",
                    "HER-2 Negative",
                    "HER2 Negative"
                ],
                "nci_thesaurus_concept_id": "C68749",
                "name": "HER2/Neu Negative",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C165233",
                    "C16612",
                    "C17756",
                    "C3367",
                    "C21295",
                    "C35681",
                    "C20719",
                    "C25870",
                    "C16152",
                    "C36292",
                    "C25872",
                    "C94299",
                    "C77140",
                    "C20103",
                    "C21281",
                    "C25871"
                ],
                "parents": [
                    "C16152",
                    "C165233",
                    "C17756"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C94299",
                "name": "Receptor Status",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C3367",
                    "C36292",
                    "C77140"
                ],
                "parents": [
                    "C36292"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C20719",
                "name": "Receptor Tyrosine Kinase Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C16612",
                    "C21295",
                    "C25870",
                    "C25872",
                    "C20103",
                    "C21281",
                    "C25871"
                ],
                "parents": [
                    "C20103",
                    "C25872"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "ERBB2 Status",
                    "Her2/Neu Value"
                ],
                "nci_thesaurus_concept_id": "C16152",
                "name": "HER2/Neu Status",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C3367",
                    "C16612",
                    "C17756",
                    "C21295",
                    "C20719",
                    "C25870",
                    "C36292",
                    "C25872",
                    "C94299",
                    "C77140",
                    "C20103",
                    "C21281",
                    "C25871"
                ],
                "parents": [
                    "C17756",
                    "C94299"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "ERBB2",
                    "Erb-b2 Receptor Tyrosine Kinase 2 Gene",
                    "HER2",
                    "HER2/Neu",
                    "NEU"
                ],
                "nci_thesaurus_concept_id": "C17756",
                "name": "ERBB2 Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [
                    "reference_gene"
                ],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C16612",
                    "C21295",
                    "C20719",
                    "C25870",
                    "C25872",
                    "C20103",
                    "C21281",
                    "C25871"
                ],
                "parents": [
                    "C20719"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C25870",
                "name": "Transferase Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C16612",
                    "C21281"
                ],
                "parents": [
                    "C21281"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C54362",
                "name": "Transcription Regulation Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C16612"
                ],
                "parents": [
                    "C16612"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TRIAL",
                "synonyms": [
                    "Negative",
                    "PGR Negative",
                    "PR Negative",
                    "PR-"
                ],
                "nci_thesaurus_concept_id": "C15497",
                "name": "Progesterone Receptor Negative",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C20420",
                    "C35681",
                    "C36292",
                    "C20709",
                    "C20103",
                    "C16612",
                    "C94299",
                    "C77140",
                    "C21295",
                    "C54362",
                    "C16149",
                    "C165233",
                    "C3367",
                    "C28656"
                ],
                "parents": [
                    "C16149",
                    "C165233",
                    "C28656"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "ER",
                    "ESR1",
                    "Estrogen Receptor 1 Gene"
                ],
                "nci_thesaurus_concept_id": "C38349",
                "name": "ESR1 Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [
                    "reference_gene"
                ],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C16612",
                    "C21295",
                    "C20420",
                    "C54362",
                    "C20103",
                    "C20709"
                ],
                "parents": [
                    "C20709"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Genes"
                ],
                "nci_thesaurus_concept_id": "C16612",
                "name": "Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [
                    "branch"
                ],
                "eligibility_criteria": "inclusion",
                "ancestors": [],
                "parents": [],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TRIAL",
                "synonyms": [
                    "ER-Negative PR-Negative ERBB2-Negative",
                    "ER-PR-HER2/neu-",
                    "ER-negative PR-negative HER2/neu-negative",
                    "ER/PR/HER2 Negative",
                    "ESR1/PGR/ERBB2 Negative Finding",
                    "Triple Negative Breast Cancer Finding",
                    "Triple Negative Breast Cancer Result",
                    "Triple-Negative Breast Cancer Result",
                    "triple-negative breast cancer"
                ],
                "nci_thesaurus_concept_id": "C71428",
                "name": "Triple-Negative Breast Cancer Finding",
                "semantic_types": [
                    "Finding"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C20103",
                    "C94299",
                    "C17756",
                    "C25871",
                    "C25872",
                    "C36292",
                    "C38349",
                    "C20709",
                    "C21281",
                    "C77140",
                    "C165233",
                    "C28656",
                    "C20420",
                    "C20719",
                    "C21295",
                    "C25870",
                    "C35681",
                    "C16612",
                    "C54362",
                    "C3367"
                ],
                "parents": [
                    "C165233",
                    "C17756",
                    "C28656",
                    "C38349",
                    "C94299"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "ER Alpha Status",
                    "ER Status",
                    "ER-Alpha Status",
                    "ERA Status",
                    "ESR Status",
                    "ESR1 Status",
                    "ESRA Status",
                    "ESTRR Status",
                    "Estrogen Receptor",
                    "Estrogen Receptor 1 Status",
                    "Estrogen Receptor Alpha Status",
                    "NR3A1 Status",
                    "Nuclear Receptor Subfamily 3 Group A Member 1 Status"
                ],
                "nci_thesaurus_concept_id": "C16150",
                "name": "Estrogen Receptor Status",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C3367",
                    "C16612",
                    "C21295",
                    "C20420",
                    "C38349",
                    "C54362",
                    "C36292",
                    "C20103",
                    "C94299",
                    "C77140",
                    "C20709"
                ],
                "parents": [
                    "C38349",
                    "C94299"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "LAB_RESULT",
                    "Lab Findings",
                    "Laboratory Finding",
                    "Laboratory Report",
                    "Labs",
                    "Test Result",
                    "test_result"
                ],
                "nci_thesaurus_concept_id": "C36292",
                "name": "Laboratory Test Result",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C3367",
                    "C77140"
                ],
                "parents": [
                    "C77140"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Negative"
                ],
                "nci_thesaurus_concept_id": "C35681",
                "name": "Negative Test Result",
                "semantic_types": [
                    "Finding"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C3367",
                    "C77140"
                ],
                "parents": [
                    "C77140"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C25871",
                "name": "Phosphotransferase Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C25870",
                    "C16612",
                    "C21281"
                ],
                "parents": [
                    "C25870"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Observable Entity"
                ],
                "nci_thesaurus_concept_id": "C3367",
                "name": "Finding",
                "semantic_types": [
                    "Finding"
                ],
                "type": [
                    "branch"
                ],
                "eligibility_criteria": "inclusion",
                "ancestors": [],
                "parents": [],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "PgR Status",
                    "Progesterone Receptor"
                ],
                "nci_thesaurus_concept_id": "C16149",
                "name": "Progesterone Receptor Status",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C20420",
                    "C36292",
                    "C16612",
                    "C20709",
                    "C20103",
                    "C94299",
                    "C21295",
                    "C77140",
                    "C54362",
                    "C3367",
                    "C28656"
                ],
                "parents": [
                    "C28656",
                    "C94299"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C20103",
                "name": "Receptor Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C16612",
                    "C21295"
                ],
                "parents": [
                    "C21295"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Proto-Oncogene, Transcription Factor"
                ],
                "nci_thesaurus_concept_id": "C20420",
                "name": "Transcription Factor Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C54362",
                    "C16612"
                ],
                "parents": [
                    "C54362"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C20709",
                "name": "Nuclear Receptor Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C16612",
                    "C21295",
                    "C20420",
                    "C54362",
                    "C20103"
                ],
                "parents": [
                    "C20103",
                    "C20420"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TRIAL",
                "synonyms": [
                    "ER Alpha Negative",
                    "ER Negative",
                    "ER-",
                    "ER-Alpha Negative",
                    "ERA Negative",
                    "ESR Negative",
                    "ESR1 Negative",
                    "ESRA Negative",
                    "ESTRR Negative",
                    "Estrogen Receptor 1 Negative",
                    "Estrogen Receptor Alpha Negative",
                    "NR3A1 Negative",
                    "Negative",
                    "Negative Estrogen Receptor",
                    "Nuclear Receptor Subfamily 3 Group A Member 1 Negative"
                ],
                "nci_thesaurus_concept_id": "C15493",
                "name": "Estrogen Receptor Negative",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C20420",
                    "C35681",
                    "C36292",
                    "C38349",
                    "C20709",
                    "C20103",
                    "C94299",
                    "C16612",
                    "C77140",
                    "C21295",
                    "C54362",
                    "C165233",
                    "C3367",
                    "C16150"
                ],
                "parents": [
                    "C16150",
                    "C165233",
                    "C38349"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C21281",
                "name": "Enzyme Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C16612"
                ],
                "parents": [
                    "C16612"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "PGR",
                    "PR",
                    "Progesterone Receptor Gene"
                ],
                "nci_thesaurus_concept_id": "C28656",
                "name": "PGR Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [
                    "reference_gene"
                ],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C16612",
                    "C21295",
                    "C20420",
                    "C54362",
                    "C20103",
                    "C20709"
                ],
                "parents": [
                    "C20709"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            }
        ],
        "classification_code": null,
        "current_trial_status_date": "2018-12-10",
        "diseases": [
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Anatomic Stage IV Breast Carcinoma AJCC v8",
                    "Anatomic Stage IV Breast Cancer AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C139545",
                "name": "Stage IV Breast Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C139533"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Prognostic Stage IV Breast Cancer AJCC v8",
                    "Prognostic Stage IV Breast Carcinoma AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C139587",
                "name": "Stage IV Breast Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C139554"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C153238",
                "name": "Metastatic Breast Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3482",
                    "C170728",
                    "C4872"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Metastatic Neoplasm to the Brain",
                    "Metastatic Tumor to the Brain",
                    "Metastases to brain parenchyma, NOS",
                    "Brain Metastases",
                    "Brain Metastasis",
                    "Metastatic Malignant Neoplasm to the Brain",
                    "Metast. to brain parenchyma, NOS"
                ],
                "nci_thesaurus_concept_id": "C3813",
                "name": "Metastatic Malignant Neoplasm in the Brain",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3568",
                    "C4015"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": true,
                "synonyms": [
                    "Triple-Negative Breast Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C71732",
                "name": "Triple-Negative Breast Cancer",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C53553"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Neoplasm, malignant",
                    "Cancer",
                    "Malignant Growth",
                    "Tumor, malignant, NOS",
                    "Malignant Tumor",
                    "Malignancy",
                    "CA",
                    "Unclassified tumor, malignant",
                    "Malignant Neoplastic Disease"
                ],
                "nci_thesaurus_concept_id": "C9305",
                "name": "Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Mammary Carcinoma",
                    "Carcinoma of Breast",
                    "Carcinoma of the Breast",
                    "Breast cancer, NOS",
                    "Cancer of Breast",
                    "Breast Carcinoma",
                    "Cancer of the Breast"
                ],
                "nci_thesaurus_concept_id": "C4872",
                "name": "Breast Cancer",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C2916",
                    "C9335"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Adenocarcinoma, NOS",
                    "ADENOCARCINOMA, MALIGNANT"
                ],
                "nci_thesaurus_concept_id": "C2852",
                "name": "Adenocarcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2916",
                    "C7132"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C7062",
                "name": "Neoplasm by Special Category",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3262"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "disease term",
                    "Disease",
                    "Diseases and Disorders",
                    "disease type",
                    "Disease or Disorder",
                    "Diagnosis",
                    "disease_term",
                    "condition",
                    "disease_type",
                    "Diseases",
                    "Disease or Disorder, Non-Neoplastic",
                    "Disorders",
                    "Disorder"
                ],
                "nci_thesaurus_concept_id": "C2991",
                "name": "Other Disease",
                "type": [
                    "maintype"
                ],
                "parents": []
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Disease by Site"
                ],
                "nci_thesaurus_concept_id": "C27551",
                "name": "Disorder by Site",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2991"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "CARCINOMA, MALIGNANT",
                    "Malignant Epithelial Tumor",
                    "Malignant Epithelial Neoplasm",
                    "Epithelial Carcinoma",
                    "Malignant Epithelioma",
                    "Carcinoma",
                    "Carcinoma, NOS",
                    "Epithelial tumor, malignant",
                    "Epithelioma Malignant"
                ],
                "nci_thesaurus_concept_id": "C2916",
                "name": "Other Carcinoma",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C3709",
                    "C9305"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Epithelioma",
                    "Epithelioma, malignant",
                    "Epithelial Neoplasms, NOS"
                ],
                "nci_thesaurus_concept_id": "C3709",
                "name": "Epithelial Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4741"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Glandular Cell Epithelium Neoplasm",
                    "Glandular Cell Epithelial Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C7132",
                "name": "Glandular Cell Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3709"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Neoplasm of Breast",
                    "Neoplasm of the Breast",
                    "Tumor of Breast",
                    "Tumor of the Breast",
                    "Breast Tumor"
                ],
                "nci_thesaurus_concept_id": "C2910",
                "name": "Breast Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3263",
                    "C26709"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Adenocarcinoma of the Breast",
                    "Mammary adenocarcinoma",
                    "Adenocarcinoma of Breast"
                ],
                "nci_thesaurus_concept_id": "C5214",
                "name": "Breast Adenocarcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4872",
                    "C2852"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Breast Disease",
                    "Breast Diseases"
                ],
                "nci_thesaurus_concept_id": "C26709",
                "name": "Breast Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C27551"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Malignant Tumor of the Breast",
                    "Malignant Neoplasm of the Breast",
                    "Malignant Neoplasm of Breast",
                    "Malignant Breast Tumor",
                    "Malignant Tumor of Breast"
                ],
                "nci_thesaurus_concept_id": "C9335",
                "name": "Malignant Breast Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2910",
                    "C9305"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Neoplasms, NOS",
                    "Neoplasia",
                    "Tumor, NOS",
                    "Neoplastic Growth",
                    "Neoplasm",
                    "Neoplastic Disease",
                    "tumor",
                    "Neoplasm, NOS"
                ],
                "nci_thesaurus_concept_id": "C3262",
                "name": "Other Neoplasm",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C2991"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C3263",
                "name": "Neoplasm by Site",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3262"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C53553",
                "name": "Breast Carcinoma by Gene Expression Profile",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C5214"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Tumor Morphology",
                    "Tumor_Morphology"
                ],
                "nci_thesaurus_concept_id": "C4741",
                "name": "Neoplasm by Morphology",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3262"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C170728",
                "name": "Metastatic Malignant Breast Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9335",
                    "C36263"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Carcinoma, metastatic, NOS"
                ],
                "nci_thesaurus_concept_id": "C3482",
                "name": "Metastatic Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C36310",
                    "C36263"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Breast Carcinoma by AJCC v8 Anatomic Stage"
                ],
                "nci_thesaurus_concept_id": "C139533",
                "name": "Breast Cancer by AJCC v8 Anatomic Stage",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C139532"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Secondary Malignant Neoplasm to the Nervous System",
                    "Metastatic Tumor to the Nervous System",
                    "Metastatic Neoplasm to the Nervous System",
                    "Metastasis to the Nervous System",
                    "Secondary Malignant Tumor to the Nervous System",
                    "Metastatic Malignant Neoplasm to the Nervous System",
                    "Metastases to Nervous System"
                ],
                "nci_thesaurus_concept_id": "C8547",
                "name": "Metastatic Malignant Neoplasm in the Nervous System",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4788",
                    "C36263"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Malignant Tumor of Brain",
                    "Cancer of the Brain",
                    "Brain Neoplasms, Malignant",
                    "Malignant Tumor of the Brain",
                    "Cancer of Brain",
                    "Brain Cancer",
                    "Malignant Neoplasm of the Brain",
                    "Malignant Neoplasm of Brain",
                    "Malignant Brain Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C3568",
                "name": "Malignant Brain Tumor",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C5114",
                    "C2907"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Neoplasm, secondary",
                    "Secondary Tumor",
                    "Tumor, secondary"
                ],
                "nci_thesaurus_concept_id": "C36255",
                "name": "Secondary Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Malignant Neoplasm of Central Nervous System",
                    "Malignant Central Nervous System Tumor",
                    "Malignant Neoplasm of CNS",
                    "Malignant CNS Tumor",
                    "Malignant CNS Neoplasms",
                    "Central Nervous System Neoplasms, Malignant",
                    "Malignant Neoplasm of the CNS",
                    "Cancer of the Central Nervous System",
                    "CNS Neoplasms, Malignant",
                    "Malignant Tumor of the CNS",
                    "Malignant CNS Neoplasm",
                    "Cancer of CNS",
                    "Central Nervous System Cancer",
                    "Malignant Neoplasm of the Central Nervous System",
                    "CNS Malignant Neoplasms",
                    "Malignant Tumor of Central Nervous System",
                    "CNS Cancer",
                    "Cancer of Central Nervous System",
                    "Cancer of the CNS",
                    "Malignant Tumor of the Central Nervous System",
                    "Malignant Tumor of CNS"
                ],
                "nci_thesaurus_concept_id": "C4627",
                "name": "Malignant Central Nervous System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4788",
                    "C9293"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Metastatic Tumor",
                    "Tumor, metastatic",
                    "Neoplasm, metastatic"
                ],
                "nci_thesaurus_concept_id": "C3261",
                "name": "Metastatic Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Metastatic Cancer"
                ],
                "nci_thesaurus_concept_id": "C36263",
                "name": "Metastatic Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4968",
                    "C3261"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Breast Carcinoma by AJCC v8 Stage"
                ],
                "nci_thesaurus_concept_id": "C139532",
                "name": "Breast Cancer by AJCC v8 Stage",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C4872"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Central Nervous System Metastasis",
                    "Metastatic Neoplasm to the Central Nervous System",
                    "Metastatic Tumor to the CNS",
                    "CNS Metastases",
                    "Metastatic Neoplasm to the CNS",
                    "CNS Metastasis",
                    "Central Nervous System Metastases",
                    "Metastatic Tumor to the Central Nervous System",
                    "Metastatic Malignant Neoplasm in the Central Nervous System"
                ],
                "nci_thesaurus_concept_id": "C4015",
                "name": "Metastatic Malignant Neoplasm to the Central Nervous System",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C8547",
                    "C4627"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Malignant Intracranial Tumor",
                    "Intracranial Cancer",
                    "Intracranial Neoplasms, Malignant",
                    "Intracranial Tumors, Malignant"
                ],
                "nci_thesaurus_concept_id": "C5114",
                "name": "Malignant Intracranial Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4627",
                    "C4953"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Central Nervous System Disease",
                    "Disorder of Central Nervous System"
                ],
                "nci_thesaurus_concept_id": "C2934",
                "name": "Central Nervous System Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C26835"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Malignant Nervous System Tumor",
                    "Nervous System Neoplasms, Malignant",
                    "Malignant Neoplasm of Nervous System",
                    "Malignant Tumor of Nervous System",
                    "Malignant Tumor of the Nervous System",
                    "Malignant Neoplasm of the Nervous System"
                ],
                "nci_thesaurus_concept_id": "C4788",
                "name": "Malignant Nervous System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9305",
                    "C3268"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Nervous System Neoplasms",
                    "Neoplasm of Nervous System",
                    "Nervous System Neoplasm",
                    "Tumor of Nervous System",
                    "Nervous System Tumour",
                    "Tumor of the Nervous System",
                    "Neoplasm of the Nervous System"
                ],
                "nci_thesaurus_concept_id": "C3268",
                "name": "Nervous System Tumor",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C26835",
                    "C3263"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Breast Cancer by AJCC v8 Prognostic Stage Group",
                    "Breast Carcinoma by AJCC v8 Prognostic Stage"
                ],
                "nci_thesaurus_concept_id": "C139554",
                "name": "Breast Cancer by AJCC v8 Prognostic Stage",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C139532"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Secondary Malignancy",
                    "Secondary Cancer"
                ],
                "nci_thesaurus_concept_id": "C4968",
                "name": "Secondary Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9305",
                    "C36255"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Intracranial Tumor",
                    "Intracranial Central Nervous System Tumor",
                    "Intracranial Central Nervous System Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C4953",
                "name": "Intracranial Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9293"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C96413",
                "name": "Brain Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2934"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Unspecified Nervous System Problem",
                    "Neurological Disorder",
                    "Disorder of Nervous System",
                    "Neurologic Disorder"
                ],
                "nci_thesaurus_concept_id": "C26835",
                "name": "Nervous System Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C27551"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C36310",
                "name": "Secondary Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4968",
                    "C2916"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Tumor of Brain",
                    "Brain Neoplasms",
                    "Brain Neoplasm",
                    "Neoplasm of the Brain",
                    "Tumor of the Brain",
                    "Neoplasm of Brain"
                ],
                "nci_thesaurus_concept_id": "C2907",
                "name": "Brain Tumor",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C96413",
                    "C4953"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Neoplasm of CNS",
                    "CNS Tumor",
                    "CNS Neoplasm",
                    "Tumor of CNS",
                    "Neoplasm of the Central Nervous System",
                    "Central Nervous System Tumor",
                    "Central Nervous System Neoplasm",
                    "Tumor of the Central Nervous System",
                    "Neoplasm of Central Nervous System",
                    "Tumor of Central Nervous System",
                    "Tumor of the CNS"
                ],
                "nci_thesaurus_concept_id": "C9293",
                "name": "Brain/Spinal Cord Tumor",
                "type": [
                    "maintype",
                    "subtype"
                ],
                "parents": [
                    "C3268",
                    "C2934"
                ]
            }
        ],
        "_primary_purpose_sort_order": 0,
        "protocol_id": "18-1832",
        "active_sites_count": 3,
        "lead_org_cancer_center": "Tisch Cancer Institute",
        "arms": [
            {
                "interventions": [
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Pharmacological Substance",
                            "Drug Substance",
                            "Pharmaceuticals",
                            "Pharmacologic Agent",
                            "Drug",
                            "Agent",
                            "Pharmaceutical Agent"
                        ],
                        "nci_thesaurus_concept_id": "C1909",
                        "name": "Pharmacologic Substance",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1908"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1971",
                        "name": "Angiogenesis Activator Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1742"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Chemotherapeutic Agents, Neoplastic Disease",
                            "Anti-Cancer Agents",
                            "Anti-Tumor Agents",
                            "Antineoplastics",
                            "Antiproliferative Agents",
                            "Antineoplastic Drugs",
                            "Anti-Tumor Drugs",
                            "Cancer Drug",
                            "Antiproliferative Drugs",
                            "Tumor-Specific Treatment Agents"
                        ],
                        "nci_thesaurus_concept_id": "C274",
                        "name": "Antineoplastic Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Enzyme Inhibitor Agent",
                            "Enzyme Antagonist",
                            "Enzyme Inhibitor Drug"
                        ],
                        "nci_thesaurus_concept_id": "C471",
                        "name": "Enzyme Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Angiogenesis Antagonists",
                            "Antiangiogenesis Agents",
                            "Angiogenesis Blockers",
                            "Anti-Angiogenic Agents",
                            "Antiangiogenic Agent"
                        ],
                        "nci_thesaurus_concept_id": "C1742",
                        "name": "Angiogenesis Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C274"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1557",
                        "name": "Pyrimidine Antagonist",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C272"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antimetabolites"
                        ],
                        "nci_thesaurus_concept_id": "C272",
                        "name": "Antimetabolite",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C274"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1908",
                        "name": "Drug, Food, Chemical or Biomedical Material",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": []
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [
                            "Arava"
                        ],
                        "nci_thesaurus_concept_id": "C1128",
                        "name": "Leflunomide",
                        "description": "A derivative of isoxazole used for its immunosuppressive and anti-inflammatory properties.  As a prodrug, leflunomide is converted to an active metabolite, A77 1726, which blocks dihydroorotate dehydrogenase, a key enzyme of de novo pyrimidine synthesis, thereby preventing the expansion of activated T lymphocytes.  This agent also inhibits various protein tyrosine kinases, such as protein kinase C (PKC), thereby inhibiting cell proliferation. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)Health professional",
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C2169",
                            "C1971",
                            "C1557"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Dihydroorotate Dehydrogenase Inhibitors"
                        ],
                        "nci_thesaurus_concept_id": "C2169",
                        "name": "Dihydroorotate Dehydrogenase Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C471"
                        ]
                    }
                ],
                "name": "Treatment (leflunomide)",
                "description": "Patients receive leflunomide PO QD in the absence of disease progression or unacceptable toxicity.",
                "type": "EXPERIMENTAL"
            }
        ],
        "study_model_code": null,
        "nci_id": "NCI-2018-02927",
        "why_study_stopped": null,
        "brief_summary": "This phase I/II trial studies the side effects, best dose and how well leflunomide works in treating patients with previously treated triple negative breast cancer (TNBC) that had spread to other places in the body (metastasis). TNBC is an aggressive form of breast cancer, especially when it is metastatic. Standard chemotherapy often works less well in TNBC than it does in other forms of breast cancer. Leflunomide may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.",
        "brief_title": "Leflunomide in Treating Patients with Previously Treated Metastatic Triple Negative Breast Cancer",
        "status_history": [
            {
                "status_date": "2018-12-10T00:00:00.000001",
                "status": "ACTIVE"
            },
            {
                "status_date": "2018-10-26T00:00:00",
                "status": "APPROVED"
            }
        ],
        "study_population_description": null,
        "sampling_method_code": null,
        "minimum_target_accrual_number": 78,
        "_current_trial_status_sort_order": 0,
        "start_date": "2018-12-10",
        "record_verification_date": "2022-02-02",
        "ctep_id": null,
        "current_trial_status": "Active",
        "study_model_other_text": null,
        "masking": {
            "role_caregiver": null,
            "masking": null,
            "role_investigator": null,
            "role_outcome_assessor": null,
            "role_subject": null,
            "allocation_code": "NA"
        },
        "acronym": null,
        "nci_funded": "Indirect",
        "anatomic_sites": [
            "Breast"
        ],
        "ccr_id": null,
        "start_date_type_code": "ACTUAL",
        "principal_investigator": "Charles Louis Shapiro",
        "study_source": "Institutional",
        "completion_date": "2025-10-31",
        "study_subtype_code": null,
        "study_protocol_type": "Interventional"
    }
]